Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS ยท Real-Time Price ยท USD
16.02
-1.03 (-6.04%)
At close: Nov 19, 2026, 4:00 PM EST
15.74
-0.28 (-1.75%)
Pre-market: Nov 20, 2026, 9:24 AM EST
Hims & Hers Health Employees
Hims & Hers Health had 2,442 employees as of December 31, 2025. The number of employees increased by 805 or 49.18% compared to the previous year. That makes Hims & Hers Health the 9,126th largest employer in the world and 1,570th in the United States.
Employees
2,442
Change (1Y)
805
Growth (1Y)
49.18%
Revenue / Employee
$1,175,065
Profits / Employee
-$78,151
Market Cap
3.76B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,442 | 805 | 49.18% |
| Dec 31, 2024 | 1,637 | 591 | 56.50% |
| Dec 31, 2023 | 1,046 | 395 | 60.68% |
| Dec 31, 2022 | 651 | 253 | 63.57% |
| Dec 31, 2021 | 398 | 217 | 119.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| HUTCHMED (China) | 1,790 |
| Lantheus Holdings | 1,193 |
| Prestige Consumer Healthcare | 890 |
| Supernus | 838 |
| Xeris Biopharma Holdings | 435 |
| Kiniksa Pharmaceuticals International, | 366 |
HIMS News
- 1 day ago - Hims & Hers pushes beyond weight loss with Peptides+, a line of compounded longevity treatments - Stock Analysis
- 2 days ago - Hims & Hers launches new peptide treatments โ while admitting there's more to learn about efficacy - CNBC
- 2 days ago - Hims & Hers Launches Peptides+, a New Clinically-Guided Specialty for Access to Personalized, Proactive Health - Business Wire
- 9 days ago - Hims & Hers Health Faces Legal Woes as Five States Join FTC Lawsuit over Privacy Practices - TipRanks
- 9 days ago - Hims & Hers falls -18.6% - TheFly
- 9 days ago - Hims & Hers (HIMS) Needs Better Profits to Justify Its Price - TipRanks
- 10 days ago - Nvidia, Hims & Hers, JBS, Take-Two, and More Stocks That Explain Today's Market - Barrons
- 10 days ago - Hims & Hers Health Earnings Call Transcript: Q3 2026 - Transcripts